L-ELISA d-aggregates human beta-amyloid quantifies human Aβ aggregates in tissue homogenate, ventricular fluid, LCR, tissue culture supernatant and human buffered solution. The dosage will recognize exclusively...
L-ELISA d-aggregates human beta-amyloid quantifies human Aβ aggregates in tissue homogenate, ventricular fluid, LCR, tissue culture supernatant and human buffered solution. The dosage will recognize only the natural and recombinant human aggregate Aβ. Principle of the L-ELISA solid phase sandwich human aggregate d-Aβ (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Beta-amyloid is a 40–43 amino acid peptide cleavage of the amyloid precursor protein and a putative gamma-secretase. The amyloid beta (1-40) and the amyloid beta (1-42) are two major C-terminal variants of the amyloid beta protein, making up the majority of the amyloid beta proteins. Alloforms beta amyloids (40) and beta amyloids (42) are major components of extracellular plaques present in the brain tissue of Alzheimer's disease. Order information
Shipping conditions: Wet ice
Measurement range
Dose range: 0.09-5.7 ng/ml.
Duration of dosing
Total duration of dosing: 4 hours.
Reproducibility
Coefficient of variation between doses 7.4%, interdose 7.4%.
Samples
Sample type: Tissue homogenates, Cephal-rachidial liquid, Ventricular liquid, Surnatant (volume Cephalachidian liquid, 100 μl; supernatant, 50 μl; tissue homogenate, 50 μl; ventricular liquid, 100 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 10766743 |
| Specifications |
| Accession number | P05067 |
| Dose range | 0.09-5.7 ng/ml |
| Sensitivity of the dosage | <0.01 ng |
| Concentration | 0.09 to 5.7 ng/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Tissue homogenates, Cephal-rachid liquid, Ventricular liquid, Surnatant |
| Target species | Human |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 351 |
| Gene symbol(s) | AAA,ABETA,ABPP,AD1I,CTFgamma,CVAP,PN-II,PN2,APP |
| Incubation time | 4 h |
| Coefficient of inter-dose variation | 7.4% |
| Coefficient of intra-dose variation | 7.4% |
| Contents of kits | 96-well pre-coated plate, Streptavidine HRP, HRP diluent, Wash pad, Chromogen, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Genetic marker | Aggregate Aβ |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Cephalachidian liquid, 100 μl; supernatant, 50 μl; tissue homogenate, 50 μl; ventricular liquid, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h |
Origin and customs
| Manufacturer ref. | KHB3491 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.